“Proceed With Caution At Your Own Peril” – Merck’s COVID ‘Super Drug’ Poses Serious Health Risks

0
61

Assessment: Some scientists who have studied the drug warn, however, that the method it uses to kill the virus that causes Covid-19 carries potential dangers that could limit the drug’s usefulness.

COVID drug molnupiravir is extremely safe weren’t faithfully adhering to “the science” after all. Because according to a report published Thursday by Barron’s, some scientists are worried that the drug – which purportedly cut hospitalizations in half during a study that was cut short – could cause cancer or birth defects.

There is a way that seems right to a man,
But its end is the way of death.” Proverbs 14:12

So much for having a “strong safety profile,” as Dr. Scott Gottlieb claimed in an interview on the day Merck first publicized the research.

It’s perfectly understandable why Merck might choose to play down this safety risk: assuming it’s approved, the drug is widely expected to be one of “the most lucrative drugs ever” – which is one reason why Merck’s shares soared into double-digit territory after the announcement.

As we reported earlier this week, Merck and its “partner” Ridgeback Biotherapeutics will profit immensely by charging customers up to 40x what it costs to make the drug, which Ridgeback originally licensed from Emory University for an “undisclosed sum”. The drug was developed with funding from the federal government.

According to Barron’s, some scientists who have studied the drug believe that its method of suppressing the virus could potentially run amok within the body. Read More

Hits: 33

This site uses Akismet to reduce spam. Learn how your comment data is processed.